Prostate cancer: Increased dementia risk following androgen deprivation therapy?

Document Type

Journal Article

Publication Title

Nature Reviews Urology

Publisher

Nature

School

School of Medical Sciences / Centre of Excellence for Alzheimer's Disease Research and Care

RAS ID

24432

Comments

Martins, R. N., & Gandy, S. (2016). Prostate cancer: Increased dementia risk following androgen deprivation therapy?. Nature Reviews Urology, 13(4), 188-189. Available here

Abstract

Although the increased use of androgen deprivation therapy for prostate cancer might be improving survival, a recent large retrospective cohort study that analysed hospital medical record data indicates that long therapy duration is associated with an increased risk of Alzheimer's disease.

DOI

10.1038/nrurol.2016.34

Access Rights

subscription content

Link to Full Text

Share

 
COinS